We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

The art of successful licensing – “A lot has to align”

Sharp research, strong data and a high level of innovation are all very good, but more than that is required to achieve the goal of many biotechnology companies...

Vaccine project targeting congenital infection scrapped in late-stage trial – “Clearly disappointed”

Hope for the first vaccine against the world’s most common congenital infection has taken a serious hit

Charged with illegal pharmaceutical sales – alleged earnings of 23 million

For at least five years, two men allegedly carried out illegal sales of pharmaceuticals and supplements, amassing millions. They are now facing charges at Söder...

Grönt ljus för Kennedy sänker läkemedelsbolag

Flera läkemedelsbolag backar på börsen efter att senatskommittén godkänt Robert F. Kennedy Jr som kandidat till landets hälsominister.

Nobel Prize winner Torsten Wiesel turns 100: “Old men like me should use their experience to help the young”

In 1955, a young Torsten Wiesel jumped on a boat to the US and embarked on a fabulous career as a neuroscientist, crowned with a Nobel Prize for his work. Now 1...

Sneak Peek of ZEISS Metrology Expert Tips Season 2

The second season of the video series starts in January 2026, but you can discover more about the highlights of Season 2 now.

Investment CEO: “The Nordics are outstanding in creating successful medtech companies”

Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology...

Cinclus licensavtal om Losecuppföljare kan ge miljarder

Cinclus Parma har ingått ett partnerskap och licencsavtal med Zentiva om kommersialisering i Europa av bolagets ledande läkemedelskandidat linaprazan glurate. A...

Eli Lilly Recruits Leading Swedish Researcher Kaj Blennow to Head Alzheimer’s Project

Eli Lilly recruits Kaj Blennow, leading Alzheimer’s researcher, as VP of neuroscience biomarker development.

Ny professur ska driva forskning om obesitas

Men start 2026 instiftas en ny professur med fokus på metabolism och obesitas vid Sahlgrenska akademin. Totalt 200 miljoner kronor investeras i den tioåriga for...

In-Depth Insights into the Most Useful ZEISS Metrology Expert Tips

Free webinar June 24th, 2025, 9:00-9:45 AM and 5:00-5:45 PM.

Astra Zenecas Calquence godkänd för ännu en cancerform inom EU

Astra Zeneca har fått EU-godkännande för att använda cancerläkemedelet Calquence tillsammans med venetoklax som första behandling för vuxna med kronisk lymfatisk leukemi.

Astra Zeneca: Camizestrant kan förbättra överlevnad

Astra Zenecas behandling förbättrar överlevnaden för bröstcancer i ett sent stadium, uppger bolaget.

Xbrane enters licensing agreement with Indian generics giant

Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.

New ATMP center inaugurated: “In the future, we will see cell and gene therapies in all clinics”

Karolinska Institutet and Karolinska University Hospital’s new ATMP center was inaugurated in Flemingsberg, south of Stockholm. “The ATMP Center is not just a p...

ZEISS showcases comprehensive workflow for full spectrum of retina care at EURETINA

ZEISS Medical Technology combines its diagnostic, surgical and digital technologies to support healthcare professionals in advancing retinal care.

Mercodia AB

Sänkt ersättning för Astra Zeneca-vd:n

Astra Zenecas vd Pascal Soriot fick finna sig i en 16-procentig sänkning av ersättningen i fjol – trots att företagets intäkter ökade med 18 procent.

Automated nitrogen analysis reduces costs per sample

N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo

Astra Zeneca i exklusivt licensavtal med Alteogen

Astra Zenecas dotterbolag ingår ett ett exklusivt licensavtal med det sydkoreanska bolaget Alteogen. Målet är att utveckla subkutana behandlingsalternativ för cancerpatienter.

AstraZeneca to use American AI platform for cancer trials

In a collaboration AstraZeneca will use an AI model from Israeli-American biotech Immunai to streamline its clinical trials in cancer.

ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin

More than 50 distinguished speakers from leading manufacturing companies.

MSD gör forskningsbrexit – lämnar Storbritannien

MSD överger sina planer på ett nytt brittiskt huvudkontor och ett forskningscenter i London värt över 12 miljarder kronor. Skälet är ett affärsklimat som blivit...